Cutting-edge machine enhances cancer treatment | News

Cancer patients are benefiting from a new state-of-the art linear accelerator, delivering more precise radiotherapy treatment and an improved patient experience.

Once fully operational, the £1.8m Varian Halcyon system will be able to treat up to 30 patients a day. 

The cutting-edge machine provides enhanced imaging and a quieter, more comfortable environment for patients. 

Unlike traditional linear accelerators, which use a C shaped arm, the Halcyon features an O shaped ring design, significantly reducing noise during treatment.

The advanced imaging capabilities allow radiotherapists to adapt treatment plans when required, often without the need for additional CT planning scans. The machine also enables extended scans for certain cancer types to be completed more efficiently. Further benefits include the introduction of surface guided radiotherapy, offering even greater accuracy and precision.

The new machine, known as Nightingale, arrived at the Trust earlier this year, with radiotherapy and medical physics teams working together to prepare it for patient care.

Naomi Lockyer, Acting Professional Head of Radiotherapy, said: “Our priority is always patient experience and innovative treatment delivery, and investing in this new technology allows us to deliver radiotherapy that is both highly precise and more comfortable. 

“The new machine is quieter, less intimidating, and faster, which can make a real difference for people who may already be feeling anxious about their treatment. By reducing treatment times and improving comfort, we can help patients feel more at ease while also ensuring more people can access the care they need, as we continue to develop our radiotherapy delivery techniques.”